Trial intelligence / Profile preview

Pegasys plus Entecavir in HBeAg-positive chronic hepatitis B

NCT00614471Phase 4Completed

Sponsor
Roche
Start
Aug 2007
Primary completion
Oct 2009
Modality
Cytokines & Interferons
Countries
2
01

Overview

A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Roche. Started Aug 2007; status: completed.

02

Drugs

pegylated interferon alpha
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00614471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00614471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call